Label-free cell imaging and tracking in 3D organoids

Journal Article (2025)
Author(s)

Rutger N.U. Kok (AMOLF Institute for Atomic and Molecular Physics)

Willem Kasper Spoelstra (AMOLF Institute for Atomic and Molecular Physics)

Max A. Betjes (AMOLF Institute for Atomic and Molecular Physics)

Jeroen S. van Zon (AMOLF Institute for Atomic and Molecular Physics)

Sander Tans (TU Delft - BN/Sander Tans Lab, Kavli institute of nanoscience Delft, AMOLF Institute for Atomic and Molecular Physics)

Research Group
BN/Sander Tans Lab
DOI related publication
https://doi.org/10.1016/j.xcrp.2025.102522
More Info
expand_more
Publication Year
2025
Language
English
Research Group
BN/Sander Tans Lab
Issue number
4
Volume number
6
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Fluorescence live-cell microscopy is one of the most frequently used techniques to study dynamic processes in organoids. However, it is often limited by laborious fluorescent reporter engineering, limited numbers of fluorescence channels, and adverse phototoxicity and protein overexpression effects. Label-free imaging is a promising alternative but not yet established for 3D cultures. Here, we introduce LabelFreeTracker, a label-free machine-learning-based method to visualize the nuclei and membranes in bright-field images of 3D mouse intestinal organoids. The approach uses U-Net neural networks trained on the bright-field transmitted light and fluorescence images of mouse intestinal organoids as obtained by standard confocal microscopy. LabelFreeTracker frees up fluorescence channels to study fluorescent reporters and allows (semi-)automated quantification of cell movement, cell shape and volume changes, proliferation, differentiation, and lineage trees. This method greatly simplifies live-cell imaging of tissue dynamics and will accelerate screening of patient-derived organoids, for which reporter engineering is not feasible.